IQVIA Holdings Inc (NYSE:IQV)
| 188.23 Delayed Data As of Mar 24 |  +0.23 / +0.12%Today’s Change | 165.75 Today|||52-Week Range 254.94 | -8.13% Year-to-Date |
Latest IQV News | Press Releases
| 2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch Mar 25 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 188.00 |
| Today’s open | 186.30 |
| Day’s range | 183.19 - 188.72 |
| Volume | 1,560,228 |
| Average volume (3 months) | 955,008 |
| Market cap | $35.1B |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +15.23% |
| Earnings growth (this year) | +2.71% |
| Earnings growth (next 5 years) | +12.88% |
| Revenue growth (last year) | +3.90% |
| P/E ratio | 32.9 |
| Price/Sales | 2.71 |
| Price/Book | 6.07 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ICLRICON PLC | -1.12 | -0.54% |
| ---- | ||
| CRLCharles River Labora... | +0.06 | +0.03% |
| EXELExelixis Inc | +0.16 | +0.87% |
Data as of 4:00pm ET, 03/24/2023
Financials
| Next reporting date | May 3, 2023 |
| EPS forecast (this quarter) | $2.41 |
| Annual revenue (last year) | $14.4B |
| Annual profit (last year) | $1.1B |
| Net profit margin | 7.57% |
Profile
Sector Health Services |
Industry Services to the Health Industry |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
